<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    MintHealth Inc.

    MintHealth Inc.

    MintHealth is a global, decentralized health platform that aligns healthcare stake...

    MintHealth is a global, decentralized health pl...

    Amount Raised:    $152,741.00
    Fundraising Status:    EC
    Filing Type:    CF
    AngioDynamics, Inc.

    AngioDynamics, Inc.

    AngioDynamics is a leading provider of innovative medical devices used by interven...

    AngioDynamics is a leading provider of innovati...

    Filing Type:    PU
    R1 RCM Inc.

    R1 RCM Inc.

    R1 is a leading provider of revenue cycle services and physician advisory services...

    R1 is a leading provider of revenue cycle servi...

    Filing Type:    PU
    EDAP TMS S.A.

    EDAP TMS S.A.

    Global leader in therapeutic ultrasound and present in the market for more than 35...

    Global leader in therapeutic ultrasound and pre...

    Filing Type:    PU
    GlycoMimetics, Inc.

    GlycoMimetics, Inc.

    At GlycoMimetics, we are committed to helping to make a difference in the lives of...

    At GlycoMimetics, we are committed to helping t...

    Filing Type:    PU
    MicroGen Vet LLC

    MicroGen Vet LLC

    The next evolution in DNA-based diagnostics. MicroGen Vet is the exclusive reselle...

    The next evolution in DNA-based diagnostics. Mi...

    Amount Raised:    $51,390.00
    Fundraising Status:    EC
    Filing Type:    CF
    Translate Bio, Inc.

    Translate Bio, Inc.

    Translate Bio is a leading mRNA therapeutics company developing a new class of pot...

    Translate Bio is a leading mRNA therapeutics co...

    Filing Type:    PU
    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical c...

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a...

    Filing Type:    PU
    KemPharm, Inc.

    KemPharm, Inc.

    KemPharmÂŽ is a clinical-stage specialty pharmaceutical company engaged in the dis...

    KemPharmÂŽ is a clinical-stage specialty pharma...

    Filing Type:    PU
    Molecular Templates, Inc.

    Molecular Templates, Inc.

    Molecular Templates is focused on the discovery, development, and commercializatio...

    Molecular Templates is focused on the discovery...

    Filing Type:    PU
    ViewRay, Inc.

    ViewRay, Inc.

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdianÂŽ the wor...

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufac...

    Filing Type:    PU
    MEI Pharma, Inc.

    MEI Pharma, Inc.

    MEI Pharma (Nasdaq: MEIP) is a San Diego-based late-stage pharmaceutical company f...

    MEI Pharma (Nasdaq: MEIP) is a San Diego-based ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.